» Articles » PMID: 20147481

Composite Measures in Psoriatic Arthritis: GRAPPA 2008

Overview
Journal J Rheumatol
Specialty Rheumatology
Date 2010 Feb 12
PMID 20147481
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

At the 2008 annual meeting of GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) in Leeds, UK, members discussed the value and current status of composite measures for the assessment of psoriatic arthritis (PsA). In plenary presentations, examples of composite measures developed for rheumatoid arthritis (RA) and ankylosing spondylitis (AS) were reviewed, followed by a presentation of the assessment of disease activity in systemic lupus erythematosus. Three recently devised composite methods of assessing activity or response in PsA also were presented. Considerable discussion followed in breakout groups, and members agreed that a new composite measure specifically for PsA is necessary. The composite measure should include components that encompass the spectrum of psoriatic disease, i.e., in addition to assessment of peripheral joints, it should include assessment of sacroiliitis, spondylitis, enthesitis, and dactylitis, as well as skin and nail disease.

Citing Articles

Core items to be included in a definition of moderate psoriatic arthritis: literature review and expert opinion.

Urruticoechea-Arana A, Alvarez-Vega J, Garcia-Vivar M, Pinto-Tasende J, Garcia de Yebenes M, Carmona L Rheumatol Int. 2024; 44(11):2327-2336.

PMID: 38969942 DOI: 10.1007/s00296-024-05644-y.


Evaluation of fatigue and its correlation with quality of life index, anxiety symptoms, depression and activity of disease in patients with psoriatic arthritis.

Carneiro C, Chaves M, Verardino G, Frade A, Guimaraes Coscarelli P, Bianchi W Clin Cosmet Investig Dermatol. 2017; 10:155-163.

PMID: 28507445 PMC: 5428766. DOI: 10.2147/CCID.S124886.


Misalignment between physicians and patient satisfaction with psoriatic arthritis disease control.

Furst D, Tran M, Sullivan E, Pike J, Piercy J, Herrera V Clin Rheumatol. 2017; 36(9):2045-2054.

PMID: 28238086 PMC: 5554474. DOI: 10.1007/s10067-017-3578-9.


A randomized placebo-controlled trial of methotrexate in psoriatic arthritis.

Kingsley G, Kowalczyk A, Taylor H, Ibrahim F, Packham J, McHugh N Rheumatology (Oxford). 2012; 51(8):1368-77.

PMID: 22344575 PMC: 3397466. DOI: 10.1093/rheumatology/kes001.


Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy--a single centre, open-label study.

Pontifex E, Gerlag D, Gogarty M, Vinkenoog M, Gibbs A, Burgman I Arthritis Res Ther. 2011; 13(1):R7.

PMID: 21272347 PMC: 3241351. DOI: 10.1186/ar3228.